Chronic clinical performance of a novel subxiphoidal pacemaker system: Early feasibility study design

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Medical Devices

Background:

• Traditional pacemakers carry risks of complications due to intracardiac leads.
• Extravascular pacemakers offer a leadless solution, potentially reducing complications and cost.
• Novel subxiphoid pacing aims to expand access to cardiac pacing therapy.

Purpose of the Study:

• To assess the feasibility, chronic safety, and performance of a novel subxiphoid pacemaker.
• To evaluate a new class of cardiac devices as an alternative to traditional pacemakers.

Main Methods:

• Open-label, non-randomized early feasibility study.
• Implantation of a novel subxiphoid pacemaker in ten patients.
• Regular monitoring of pacing parameters, ECG, troponin, and adverse events.

Main Results:

• Data on implantation success and chronic performance will be collected.
• Safety and efficacy of the extravascular pacemaker will be determined.
• Feasibility of the subxiphoid implantation technique will be assessed.

Conclusions:

• The study will provide data on the potential of this novel extravascular pacemaker.
• Findings will indicate if the device is a viable alternative to conventional pacemakers.
• This research contributes to the advancement of leadless cardiac pacing technology.